ASPIRIN and HEALTH
Based on quality evidence, doctors prescribe daily low-dose aspirin to people who have had a heart attack or stroke to help prevent that event from reoccurring. This is known as ‘secondary prevention’. ASPREE was a clinical trial to determine whether aspirin helped older people to live well for longer by delaying the onset of illnesses in the first place (called ‘primary prevention’) and if the benefits outweighed potential adverse effects of aspirin, such as bleeding.
ASPREE and the ASPREE-XT studies, will determine for the first time, aspirin’s short term and longer term effects in healthy older people.